By 9jaeye 
Rwanda is currently grappling with its first-ever outbreak of the Marburg virus disease (MVD), a highly contagious and deadly virus similar to Ebola. The World Health Organization (WHO) and Rwandan health authorities confirmed the outbreak on September 28, 2024, after detecting cases in several districts across the country. As of the latest reports, 26 cases have been confirmed, with six deaths attributed to the virus. This development marks a significant public health challenge for Rwanda, as the country has never dealt with such a virus outbreak before.
Symptoms and Mortality Rate of the Marburg Virus
The Marburg virus, a viral hemorrhagic fever, causes severe symptoms such as high fever, headaches, vomiting, and internal bleeding. In some cases, death can occur within 8 to 9 days due to massive blood loss and shock. The virus has an alarmingly high mortality rate, with fatality percentages ranging from 24% to 88%, depending on the outbreak and the healthcare response.
Efforts to Contain the Outbreak
The Rwandan Ministry of Health, led by Dr. Sabin Nsanzimana, has initiated extensive measures to contain the outbreak, which includes isolating infected individuals, rigorous contact tracing, and implementing strict infection control protocols at health facilities.
Impact on Healthcare Workers
Most of the confirmed cases and deaths have occurred among healthcare workers, particularly those in intensive care units. This has put a further strain on Rwanda’s medical infrastructure. Authorities have urged the public to stay vigilant, encouraging people to report symptoms such as high fever, vomiting, or diarrhea to nearby health centers immediately. Despite the seriousness of the outbreak, the Rwandan government has asked the public not to panic and to continue daily activities while adhering to preventive measures(wsws).
Global Support and Vaccine Trials
The international community, including neighboring countries, has placed Rwanda on high alert. Efforts to step up cross-border containment measures are underway to prevent the virus from spreading. WHO has also sent emergency medical supplies and mobilized experts to help Rwanda’s health authorities handle the outbreak more effectively. Although there are no approved vaccines for Marburg virus disease, several vaccine candidates are currently undergoing clinical trials(afro.who).
For more updates, visit WHO and also updated on 9ja Eye News.